Moderna uses AI for faster vaccine development

Moderna is significantly accelerating drug development timelines by leveraging artificial intelligence. Traditionally, creating a new medicine can take over a decade and cost billions. The company aims to launch new products fifteen times faster over the next five years, a goal heavily reliant on AI integration. This strategic shift could drastically reduce the time it takes for life-saving vaccines and treatments, like one for Hantavirus, to reach patients.